The legacy of Viagra and its impact on the pharmaceutical landscape presents a thorny question for investors . Initially a hugely successful drug, copycat medications have significantly diminished its market presence , creating obstacles for companies involved to the original patent holder and similar formulas. While certain firms might profit from